For US residents only.

Made for BRAF+ melanoma

TAFINLAR + MEKINIST is a treatment option for patients with BRAF+ advanced melanoma.

Important Safety Information:

TAFINLAR and MEKINIST may cause serious side effects, including the risk of new cancers: TAFINLAR, when used in combination with MEKINIST, may cause a type of skin cancer called cutaneous squamous cel...

See More
Approved Use:

TAFINLAR and MEKINIST are prescription medicines that can be used in combination to treat people with a type of skin cancer called melanoma:

 

  • That has spread to other parts of the body (metastatic) or cannot be removed by surgery (unresectable), and
  • That has a certain type of abnor...
See More
learn more about

BRAF+ Advanced Melanoma

Learn why targeted therapies, like TAFINLAR® (dabrafenib) + MEKINIST® (trametinib), are an appropriate treatment option for patients with BRAF+ advanced melanoma.

Learn More
learn more about

Tafinlar + Mekinist

TAFINLAR + MEKINIST is a combination of 2 therapies. TAFINLAR + MEKINIST can be used to treat people with advanced melanoma that has

  • spread to other parts of the body (for example, the liver, lungs, and brain) or cannot be removed by surgery, and
  • a certain type of abnormal BRAF (V600E or V600K mutation-positive) gene as determined by an FDA-approved test
Learn More